Drug profile · INN
insulin glargine-aglr
REZVOGLAR
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
insulin glargine-aglr (REZVOGLAR) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN insulin glargine-aglr
Brand REZVOGLAR
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is insulin glargine-aglr?
insulin glargine-aglr (REZVOGLAR) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for insulin glargine-aglr?
REZVOGLAR is a marketed brand name for insulin glargine-aglr. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of insulin glargine-aglr?
insulin glargine-aglr has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.